Columbia engineers invent a noninvasive technique to correct vision
(Columbia University School of Engineering and Applied Science) Columbia engineers have developed a noninvasive approach to permanently correct vision that shows great promise in preclinical models. The method uses a femtosecond oscillator for selective and localized alteration of the biochemical and biomechanical properties of corneal tissue. The technique, which changes the tissue's macroscopic geometry, is non-surgical and has fewer side effects and limitations than those seen in refractive surgeries. The study could lead to treatment for myopia, hyperopia, astigmatism, and irregular astigmatism. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 29, 2018 Category: Biology Source Type: news

FDA Clears Way For First Contact Lenses With Light-Adaptive Technology
BOSTON (CBS) – More than 40-million Americans wear contact lenses and today the FDA cleared the way for the first contact lens with light-adaptive technology. The Johnson & Johnson’s ACUVUE OASYS soft lenses darken when exposed to light similar to eyeglasses that do the same. The lenses contain an additive that changes the degree of light filtered to the eye based on the amount of UV light exposure. A clinical study found the lenses do not interfere with vision or driving performance. They can be used in people who are nearsighted or farsighted and even with a certain degree of astigmatism, an abnormal curv...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 11, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Contact Lenses Dr. Mallika Marshall FDA Source Type: news

Challenges of Treating Irregular Astigmatism: Ophthalmology Times
(MedPage Today) -- Also, how to handle change (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 31, 2018 Category: American Health Source Type: news

Johnson and Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISM
Nearly half of vision-corrected patients has astigmatism in at least one eye,(1) and full correction can provide improved visual quality of life(2) JACKSONVILLE, Fla., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision ... Devices, Ophthalmology, Product Launch Johnson & Johnson, Johnson & Johnson Vision, ACUVUE MOIST (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

RxSight wins FDA nod for light-adjustable IOL
The FDA has cleared RxSight‘s implantable light adjustable intraocular lens and light delivery device. The company’s RxSight IOL is designed from a UV light reactive material meant to be treated by a specific Light Delivery Device, intended for use 17 to 21 days post-procedure. The lens is designed to be treated by 3-4 light treatments over 1 to 2 weeks in 40 to 150 second treatment periods, during which the patient must wear UV-protective glasses. “Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery. This syste...
Source: Mass Device - November 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance rxsight Source Type: news

Measuring mental workload: ocular astigmatism aberration as a novel objective index - Jim énez R, Cardenas D, Anera RG, Jiménez JR, Vera J.
This study assessed the effect of two perceptually matched mental tasks with different levels of mental demand on ocular aberrations in a group of young adults. We measured ocular aberration with a wave-front sensor, and total, internal, and corneal RMS (r... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Minimizing Astigmatism in Cataract Surgery Minimizing Astigmatism in Cataract Surgery
Is intraoperative aberrometry or intraoperative markerless guidance more effective in helping to achieve low amounts of astigmatism after cataract surgery? Dr Garg reviews a recent study.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2017 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Can You Go Blind from Astigmatism?
Title: Can You Go Blind from Astigmatism?Category: Doctor's& Expert's views on SymptomsCreated: 10/16/2017 12:00:00 AMLast Editorial Review: 10/16/2017 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - October 16, 2017 Category: Opthalmology Source Type: news

Can Astigmatism Go Away on Its Own?
Title: Can Astigmatism Go Away on Its Own?Category: Doctor's& Expert's views on SymptomsCreated: 10/10/2017 12:00:00 AMLast Editorial Review: 10/10/2017 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - October 10, 2017 Category: Opthalmology Source Type: news

Is Astigmatism Hereditary?
Title: Is Astigmatism Hereditary?Category: Doctor's& Expert's views on SymptomsCreated: 10/9/2017 12:00:00 AMLast Editorial Review: 10/9/2017 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - October 9, 2017 Category: Opthalmology Source Type: news

7 medtech stories we missed this week: Sept. 15, 2017
[Image from unsplash.com]From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to lead its Restrata wound matrix study. The study will surgery the clinical outcomes of Restrata treatments for diabetic foot ulcers and test for effectiveness and safety. Restrata is a fully synthetic wound matrix that is FDA-cleared for ...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Dental Diagnostics Food & Drug Administration (FDA) Regulatory/Compliance Surgical Acera Surgical Contego Medical Fresenius MedTech OBP Medical Pinnacle Sciences Plusoptix Telos Source Type: news

KC eye doc: New LASIK procedure could grow patient base
Dr. John Doane said a growing number of patients are coming to his office for a new surgical alternative to LASIK. Recently approved by the Food and Drug Administration (FDA) to treat nearsighted patients, small incision lenticule extraction (SMILE) makes a tiny incision in the outer cornea, for a shorter recovery time and fewer dry-eye side effects. Doane participated in a clinical trial starting in 2013 and expects it will be approved to treat astigmatism in mid-2018. An opthalmologist at Discover… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 15, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

KC eye doc: New LASIK procedure could grow patient base
Dr. John Doane said a growing number of patients are coming to his office for a new surgical alternative to LASIK. Recently approved by the Food and Drug Administration (FDA) to treat nearsighted patients, small incision lenticule extraction (SMILE) makes a tiny incision in the outer cornea, for a shorter recovery time and fewer dry-eye side effects. Doane participated in a clinical trial starting in 2013 and expects it will be approved to treat astigmatism in mid-2018. An opthalmologist at Discover… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 15, 2017 Category: Biotechnology Authors: Elise Reuter Source Type: news

Bausch and Lomb ULTRA(R) for Astigmatism Contact Lenses Introduced
Innovative Toric Lens Delivers All-Day Comfort and Consistently Clear Vision1 LAVAL, Quebec, March 30, 2017 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bau... Devices, Ophthalmology, Product Launch Bausch & Lomb, ULTRA for Astigmatism, Astigmatism, contact lens (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2017 Category: Pharmaceuticals Source Type: news

Bausch and Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
New Innovative Daily Disposable Contact Lens Designed to Provide Astigmatic Patients Consistently Clear Vision and Comfort Throughout the Day LAVAL, Quebec, March 15, 2017 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals Interna... Devices, Ophthalmology, Product Launch Bausch & Lomb, Valeant Pharmaceuticals, Biotrue, Astigmatism, contact lens (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2017 Category: Pharmaceuticals Source Type: news

FDA Clears New Corrective Intraocular Lens From Alcon FDA Clears New Corrective Intraocular Lens From Alcon
The AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL corrects presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults.FDA Approvals (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - February 3, 2017 Category: Opthalmology Tags: Ophthalmology News Alert Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 27, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA approves Alcon’s AcrySof IQ ReStor intraocular lens Novartis‘ eye care business, Alcon, said today that it won FDA approval for its AcrySof IQ ReStor multifocal toric intraocular lens. The lens treats presbyopia...
Source: Mass Device - December 27, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA approves Alcon ’ s AcrySof IQ ReStor intraocular lens
Novartis‘ (NYSE:NVS) eye care business, Alcon, said today that it won FDA approval for its AcrySof IQ ReStor multifocal toric intraocular lens. The lens treats presbyopia and pre-existing corneal astigmatism in adult patients undergoing cataract surgery. The AcrySof IQ ReStor intraocular lens is already commercially available in the E.U., Australia, Canada, parts of Central and South America and Asia. “The AcrySof IQ ReSTOR +3.0D Multifocal Toric IOL is an important addition to our market-leading IOL portfolio, and broadens our offering of presbyopia- and astigmatism-correcting lenses to meet the different visu...
Source: Mass Device - December 23, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Clearance Wall Street Beat Alcon Novartis AG Source Type: news

Lensar files for Chapter 11 bankruptcy
Lensar Inc. today filed for Chapter 11 bankruptcy protection, saying it needs to reduce its debt and strengthen its balance sheet and platform for future growth. The Orlando, Fl.-based company was supported by its senior secured lender, PDL BioParhma Inc. In December 2015, healthcare and social commerce company Alphaeon bought the laser cataract treatment company for $59 million. Lensar said it anticipates that the company will file a plan to reduce its debt and convert a portion of PDL’s outstanding debt into equity. In the meantime, Lensar will continue to pay all employee wages and provide benefits, as w...
Source: Mass Device - December 19, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Legal News Optical/Ophthalmic Wall Street Beat LensAR Inc. Source Type: news

Staar Surgical wins Health Canada nod for Visian Toric ICL
Staar Surgical (NSDQ:STAA) said today it won approval from Health Canada’s Medical Devices Bureau for its Evo Visian Toric ICL intraocular lenses. The Evo Visian Toric ICL is designed to be implanted inside the eye between the iris and the natural lens indefinitely to correct vision, Monrovia, Calif.-based Staar Surgical said. “We are very pleased with Health Canada’s approval that allows us to offer the EVO Toric ICL for myopia and astigmatism, with a broad spherical power range of -3.0 to -18.0 diopters and cylinder power range of 1.0 to 6.0 diopters, to our surgeons and their patients in Canada. This r...
Source: Mass Device - September 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Optical/Ophthalmic Regulatory/Compliance STAAR Surgical Co Source Type: news

Staar Surgical inks 44-hospital distribution deal in India
Staar Surgical (NSDQ:STAA) said yesterday it inked a distribution agreement with India-based EyeQ Vision Private to distribute Staar Evo Visian ICL intraocular lenses as a treatment for refractive vision treatment. The deal includes supplying the lenses to 44 hospitals in north and west India, with plans to increase the number to 70 hospitals, including south and west India, within the next 2 years. “With expansion plans to grow from our 44 hospitals in North and West India to over 70 hospitals including South and West India within the next two years, we made the decision to partner with STAAR Surgical to o...
Source: Mass Device - September 16, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Distribution Optical/Ophthalmic STAAR Surgical Co Source Type: news

'Internal astigmatism' doesn't compensate for changes in the eye over time
(Wolters Kluwer Health) For people with nearsightedness (myopia), the lens doesn't compensate for growth or other changes in the structure of the eye, according to a long-term follow-up study in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2016 Category: Global & Universal Source Type: news

A'Symfony' of Hope for Cataract Patients A'Symfony' of Hope for Cataract Patients
From distance and near vision to astigmatism and chromatic aberration, the new Symfony intraocular lens seems to correct it all.Wills Eye Hospital (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 12, 2016 Category: Drugs & Pharmacology Tags: Ophthalmology Commentary Source Type: news

MassDevice.com +5 | The top 5 medtech stories for July 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. T2 Biosystems, Bayer ink blood disorder deal T2 Biosystems said today that it inked a deal with Bayer for research on blood coagulation disorders. The deal calls for T2 to provide its T2MR magnetic resonance-based diagnostic de...
Source: Mass Device - July 18, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA approves Abbott’s Tecnis Symfony lens for cataracts
The FDA last week granted pre-market approval to the Tecnis Symfony intraocular lens made by Abbott Medical Optics (NYSE:ABT) for treating patients with cataracts. The device is the 1st intra-ocular lens to provide extended depth of focus for better vision at near, intermediate and far distances, the federal safety watchdog said. Abbott said the FDA also approved a version for patients with astigmatism called the Tecnis Symfony Toric intraocular lens. “Abbott is focused on improving people’s vision and their lives by helping them stay healthy and active. Symfony offers patients, including those with astigm...
Source: Mass Device - July 18, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Abbott Source Type: news

FDA Approves the Tecnis Symfony® Intraocular Lenses, the First and Only Extended Depth of Focus Lenses for People with Cataracts
- Approval includes Toric version of Symfony IOL for people with astigmatism (Source: Abbott.com)
Source: Abbott.com - July 15, 2016 Category: Pharmaceuticals Source Type: news

FDA Approves the Tecnis Symfony ® Intraocular Lenses, the First and Only Extended Depth of Focus Lenses for People with Cataracts
- Approval includes Toric version of Symfony IOL for people with astigmatism (Source: Abbott.com)
Source: Abbott.com - July 15, 2016 Category: Pharmaceuticals Source Type: news

Astigmatism
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 5, 2016 Category: Journals (General) Source Type: news

FDA releases May 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 TOTAL 510(k)s THIS PERIOD 213 TOTAL WITH SUMMARIES 205 TOTAL WITH STATEMENTS 8 May 2016 510(k) Clearances SHARE TWEET LINKEDIN PIN IT EMAIL PRINT 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 DEVICE: O-PEP PARI RESPIRATORY EQUIPMENT, INC. 510(k) NO: K150044(Traditional) ATTN: Michael Judge PHONE NO : 1 804 2537274 2412 PARI Way SE DECISION MADE: 27-MAY-16 Midlothian VA 23112 510(k) SUMMARY AVAILABLE FROM FDA ...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 17, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Biostage unveils $5 million offering for organ regeneration tech Organ regeneration specialist Biostage, formerly know as Harvard Apparatus Regenerative Technology, announced that it will offer $5 million worth of common stock ...
Source: Mass Device - May 17, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Staar Surgical wins Health Canada nod as shares hit 52-week low
Implantable contact lens maker Staar Surgical (NSDQ:STAA) said it earned Health Canada approval to sell its EVO Visian ICL in the country. The device to correct myopia and astigmatism is permanently implanted between the iris and the eye’s natural lens. Staar sells 3 implantable lenses under its Visian franchise, but none are available in the U.S., according to the company’s website. “We are very pleased with Health Canada’s approval that allows us to offer the EVO ICL for myopia, with a broad power range of -3.0 to -18.0 diopters, to our surgeons and their patients in Canada. This represe...
Source: Mass Device - May 17, 2016 Category: Medical Equipment Authors: Varun Saxena Tags: MassDevice Earnings Roundup Optical/Ophthalmic Regulatory/Compliance Wall Street Beat Source Type: news

FDA releases February 2016 510(k) clearances
February 2016 510(k) Clearances 510(k) summaries or 510(k) statements for final decisions rendered during the period February 2016. TOTAL 510(k)s THIS PERIOD 224 TOTAL WITH SUMMARIES 213 TOTAL WITH STATEMENTS 11 February 2016 510(k) Clearances 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD February 2016 DEVICE: ANI Monitor MDOLORIS MEDICAL SYSTEMS SAS 510(k) NO: K142969(Traditional) ATTN: MATHILDE COLLET PHONE NO : 011 333 62092081 6, RUE DU PR LAGUESSE SE DECISION MADE: 23-FEB-16 LILLE FR 59037 510(k) SUMMARY AVAILABLE FROM FDA DEVICE: DBSWIN and VistaEasy Imaging Software Durr Dental...
Source: Mass Device - April 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Medtech approvals: FDA releases December 2015 PMAs
The Food & Drug Administration today released a list of pre-market approvals granted in December 2015: Summary of PMA Originals & Supplements Approved Originals: 2 Supplements: 81 Summary of PMA Originals Under Review Total Under Review: 58 Total Active: 32 Total On Hold: 26 Summary of PMA Supplements Under Review Total Under Review: 599 Total Active: 423 Total On Hold: 176 Summary of All PMA Submissions Originals: 3 Supplements: 92 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 81 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 163.1 FDA Time: 140....
Source: Mass Device - February 2, 2016 Category: Medical Equipment Authors: MassDevice Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Medtech approvals: FDA releases October 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in October 2015: Summary of PMA Originals & Supplements Approved Originals: 9 Supplements: 133 Summary of PMA Originals Under Review Total Under Review: 58 Total Active: 32 Total On Hold: 26 Summary of PMA Supplements Under Review Total Under Review: 597 Total Active: 433 Total On Hold: 164 Summary of All PMA Submissions Originals: 7 Supplements: 74 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 133 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 161.5 FDA Ti...
Source: Mass Device - December 4, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Health Tip: Managing Astigmatism
Title: Health Tip: Managing AstigmatismCategory: Health NewsCreated: 10/27/2015 12:00:00 AMLast Editorial Review: 10/27/2015 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - October 27, 2015 Category: Opthalmology Source Type: news

Medtech approvals: FDA releases May 2015 PMAs
The FDA today released its list of the pre-market approvals it granted for medical devices in May 2015: Summary of PMA Originals & Supplements Approved Originals: 5 Supplements: 51 Summary of PMA Originals Under Review Total Under Review: 55 Total Active: 26 Total On Hold: 29 Summary of PMA Supplements Under Review Total Under Review: 547 Total Active: 379 Total On Hold: 168 Summary of All PMA Submissions Originals: 1 Supplements: 62 Summary of PMA Supplement PMA Approval/Denial Decision Times Number of Approvals: 51 Number of Denials: 0 Average Days Fr Receipt to Decision (Total Time): 109.5 FDA Time: 86...
Source: Mass Device - August 6, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

Cataract Basics and Beyond: Why Treatments Are Now Better Than Ever
Kira Manusis, MD Assistant Professor of Ophthalmology Co-Director, Cataract, Cornea and Refractive Surgery New York Eye and Ear Infirmary of Mount Sinai __________________________ If you are fortunate to live long enough, you will probably develop a cataract, the leading cause of vision loss in the United States. According to the National Eye Institute, more than half of all Americans develop a cataract by age 80. As our nation's senior population expands, the number of people aged 40 or older with cataracts is expected to double from 24.4 million to about 50 million by 2050. Cataract Basics A cataract is a clouding ...
Source: Healthy Living - The Huffington Post - June 10, 2015 Category: Consumer Health News Source Type: news

Consumer Information on: STAR S4 IR Excimer Laser System and iDesign Advanced WaveScan Studio System - P930016S044
The STAR S4 IR Excimer Laser System (Laser System) and iDesign Advanced WaveScan Studio System (iDesign System) reduces or eliminates nearsightedness (myopia) and/or astigmatism. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - June 5, 2015 Category: Medical Equipment Source Type: news

Outcomes After Diffractive Multifocal Toric IOL ImplantationOutcomes After Diffractive Multifocal Toric IOL Implantation
An evaluation of this procedure finds good visual and refractive outcomes in patients with corneal astigmatism. The British Journal of Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2015 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Toric Lens May Improve Astigmatism After Cataract RemovalToric Lens May Improve Astigmatism After Cataract Removal
The toric intraocular lens also proved rotationally stable, but not everyone has found the data to be convincing. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 27, 2015 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Pioneering plastic lens combats poor vision and cataracts
The lenses, offered at London’s Claremont Clinic for around £3,900 each, promise to restore vision to those plagued by failing eyesight as well as cataracts or astigmatism. (Source: the Mail online | Health)
Source: the Mail online | Health - December 22, 2014 Category: Consumer Health News Source Type: news

Revolutionary lens restores complete vision to ageing eyes
New implant improves vision for older people struggling with cataracts, astigmatism, or long and short-sightedness. (Source: Telegraph Health)
Source: Telegraph Health - December 22, 2014 Category: Consumer Health News Tags: lenses short sighted. vision. restore long sighted catarcts Source Type: news

FDA Advisory Panel Views Intraocular Lens Favorably FDA Advisory Panel Views Intraocular Lens Favorably
The FDA Ophthalmic Device Panel has voted nearly unanimously in favor of Alcon's combination product that corrects both presbyopia and astigmatism. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2014 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

FDA Panel Recommends Intraocular Lens for AstigmatismFDA Panel Recommends Intraocular Lens for Astigmatism
An FDA panel has recommended approval for Staar's Visian toric lens for treatment of astigmatism, with reservations. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2014 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

UPDATE: Staar Surgical jumps on FDA panel nod
An FDA panel votes to recommend approval of Staar Surgical's Visian Toric implantable collamer lens for treating myopic astigmatism, sending shares up today on Wall Street. An FDA advisory panel voted last week to recommend approval for Staar Surgical's (NSDQ:STAA) Visian Toric implantable collamer lens for myopic astigmatism, sending STAA shares up nearly 17% today. Food & Drug Administration (FDA), STAAR Surgical Co.News Well, Optical/Ophthalmic, Regulatory/Complianceread more (Source: Mass Device)
Source: Mass Device - March 17, 2014 Category: Medical Equipment Authors: Ingrid Mezo Source Type: news

FDA panel recommends approval of Staar Surgical's novel eye implant
The FDA's ophthalmic devices advisory panel votes that Staar Surgical's breakthrough implantable lens is safe and effective and that its benefits outweigh its risks. An FDA panel voted today to recommend approval for Staar Surgical's (NSDQ:STAA) novel Visian Toric implantable collamer lens for treatment of myopic astigmatism in adults aged 21-45. Food & Drug Administration (FDA), STAAR Surgical Co.News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Optical/Ophthalmic, Pre-Market Approval (PMA)read more (Source: Mass Device)
Source: Mass Device - March 14, 2014 Category: Medical Equipment Authors: Ingrid Mezo Source Type: news

Better Solutions for AstigmatismBetter Solutions for Astigmatism
Dr. Roger Steinert reports how astigmatism correction during cataract surgery is improving, a fraction of a diopter at a time. Medscape Ophthalmology (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - February 19, 2014 Category: Opthalmology Tags: Ophthalmology Commentary Source Type: news

Varioptic Launches A Variable Focus, Tilt And Astigmatism Liquid Lens For Ophthalmology Applications
Varioptic, a Business Unit of Parrot SA, will announce its new Visayan series of products dedicated to the ophthalmology market at the Photonics West trade show, which will be held from February 4 to 6, 2014 in San Francisco, California. (Source: Medical Design Online News)
Source: Medical Design Online News - February 3, 2014 Category: Medical Equipment Source Type: news

Visual performance and ocular abnormalities in deaf children and young adults: A literature review - Hollingsworth R, Ludlow AK, Wilkins A, Calver R, Allen PM.
Visual defects are common in deaf individuals. Refractive error and ocular motor abnormalities are frequently reported, with hyperopia, myopia, astigmatism and anomalies of binocular vision, all showing a greater prevalence in deaf individuals compared wit... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - December 25, 2013 Category: Global & Universal Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Consumer Information on: Nidek EC-5000 Excimer Laser System - P970053/S011
The Nidek EC-5000 Excimer Laser System is an ophthalmic laser system for refractive surgery of the cornea designed to correct the vision of patients with refractive errors (nearsightedness and astigmatism) by laser assisted in-situ keratomileusis (LASIK). (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - October 30, 2013 Category: Medical Equipment Source Type: news